-
December 08, 2014
Longtime Merck & Co. confidante David Shine of Fried Frank Harris Shriver & Jacobson LLP helped steer the pharmaceutical giant through the $14.2 billion spinoff of its consumer products line to Bayer AG earlier this year, placing him solidly on Law360’s 2014 list of Life Sciences MVPs.
-
December 05, 2014
White & Case LLP’s Robert A. Milne has successfully fought to shield pay-for-delay deals involving Pfizer Inc. and Actavis PLC from antitrust liability in the wake of a major U.S. Supreme Court decision, scoring him a spot on Law360's list of Life Sciences MVPs.
-
December 04, 2014
Helping Sunovion Pharmaceuticals Inc. reverse a noninfringement finding for patents covering its blockbuster sleep aid Lunesta and secure six additional months of exclusivity worth $1 million a day to the company has earned Paul Hastings LLP partner Joe O’Malley a spot on Law360’s list of Life Sciences MVPs.
-
December 03, 2014
Kirkland & Ellis LLP's Jay Lefkowitz has had a busy year setting precedent that requires voluminous state tort claims to move forward in federal court and securing other victories for clients across the life sciences industry, landing on Law360's Life Sciences MVP list for the third year in a row.
-
December 02, 2014
Sullivan & Cromwell LLP’s Matt Hurd has been a central figure in structuring and closing some of last year’s largest and most controversial pharmaceuticals deals, including the aborted AbbVie Inc. takeover of Shire PLC, making him a natural fit among Law360’s Life Sciences MVPs.
-
November 26, 2014
White & Case LLP partner Dimitrios Drivas, the chair of the firm’s global intellectual property practice group out of its New York office, won key victories for major pharmaceutical companies over the past year that helped to earn him a place on Law360's list of Life Sciences MVPs for 2014.
-
November 18, 2014
Beginning this week, Law360 will profile those elite attorneys whose successes in high-stakes litigation, record-breaking deals and complex global matters earned them a spot on this year's list of MVP award winners.
-
December 17, 2013
Fish & Richardson PC's Jonathan E. Singer in 2013 sealed a major Federal Circuit victory directing courts to look at all objective facts when deciding the obviousness of drug patents, one of several high-profile triumphs that scored him a spot among Law360's Life Sciences MVPs.
-
December 16, 2013
Kirkland & Ellis LLP’s Jay P. Lefkowitz took home the gold this year when he won the high-profile U.S. Supreme Court case that overturned a landmark ruling on generic-drug companies’ liability with respect to state tort claims, landing him a spot among Law360’s 2013 Life Sciences MVPs.
-
December 13, 2013
Morrison & Foerster LLP partner David C. Doyle has successfully fought for generic drug companies’ access to markets years before competitors’ exclusivity runs out, including Sandoz Inc.’s bid to invalidate Teva Pharmaceutical USA Inc.’s patents for its $3 billion a year Copaxone drug, netting him a spot on Law360’s list of Life Sciences MVPs.
-
December 12, 2013
White & Case LLP's Dimitrios Drivas leverages his background in biochemistry and his nearly 30 years of experience representing major pharmaceutical companies to net victories for his clients when billion-dollar inventions are at stake, including a battle over the world's top-selling drug of all time, earning him a spot on Law360's list of 2013 Life Sciences MVPs.
-
December 11, 2013
This past year, Sullivan & Cromwell LLP's Frank Aquila guided Amgen Inc. in its $10.4 billion acquisition of Onyx Pharmaceuticals Inc., strengthening the biotechnology firm's cancer drug portfolio and earning him a spot among Law360's Life Sciences MVPs of 2013.
-
November 08, 2013
Beginning this week, Law360 will profile the elite law firm partners whose exemplary work on critical litigation, mammoth deals and first-of-their-kind global matters earned them a spot on this year's list of MVP award winners.
-
December 06, 2012
A career spent guiding pharmaceutical and biotechnology developers through the life cycle of their products, from development and patent protection to litigation — including a victory for Wake Forest University in August with billion-dollar implications — has earned Weil Gotshal & Manges LLP's Liz Weiswasser a spot on Law360's list of Life Sciences MVPs.
-
December 05, 2012
Randall Sunberg of Morgan Lewis & Bockius LLP spent the last year facilitating collaborations among pharmaceutical companies, including a nearly $2 billion multidrug deal between H. Lundbeck A/S and Otsuka Pharmaceutical Co. Ltd., earning him a spot among Law360's Life Sciences MVPs.
-
December 04, 2012
O'Melveny & Myers LLP partner Paul Scrivano has a broad mergers and acquisitions practice, but it is his work on cross-border deals involving the cutting edge of the biotech industry and an innovative investment in a Georgia firm that earned him a spot on Law360's list of Life Sciences MVPs.
-
December 03, 2012
Kirkland & Ellis LLP partner Jay Lefkowitz has had a starring role in some of the year’s most significant life sciences cases, including the Supreme Court’s recent decision to review a ruling that will mark the first significant test of its landmark Mensing judgment, earning him a spot among Law360's Life Sciences MVPs.
-
November 30, 2012
Helping Eli Lilly and Co. unwind a complicated joint venture as part of a $1.65 billion deal was just one of a number of significant transactions led by Covington & Burling LLP's John Hurvitz this year, earning him a spot on Law360's list of Life Sciences MVPs.
-
November 30, 2012
Over the next several weeks, Law360 will profile the winners of this year's MVP awards honoring attorneys whose achievements in major litigation or transactions have set a new standard for accomplishment in corporate law.